Riffyn Blog

Author: Timothy Gardner

Riffyn Nexus (Riffyn SDE) Published in a Ground-breaking Study in the Journal Scientific Data
Timothy Gardner
Riffyn SDE was created to address the crisis in scientific reproducibility and demands for more cost-efficient drug development. Its potential to transform the quality and reusability of scientific work was demonstrated in a study published in Scientific Data by Delft University of Technology.
Riffyn Launches Open Access for Scientists at Non-Profits
Timothy Gardner
To celebrate the ground-breaking publication of Riffyn SDE in the journal Scientific Data, Riffyn is launching Open Access which provides free use of the SDE for next-generation design and publishing of experiments.

Sign up for Riffyn News

Follow Riffyn on our journey to help R&D teams discover more

2X faster to market

Novozymes delivers four break-through biofuels products to market in half the normal development time with transformative digital infrastructure.

Get the case study
Riffyn Breaks New Ground in Scientific Data & Sharing
Timothy Gardner
Just a few miles away from the birthplace of microbiology, the Pronk Lab in the Department of Industrial Microbiology at Technical University Delft has completed a complex study of yeast physiology using Riffyn SDE. This is a first-of-kind use of Riffyn SDE for scientific publishing.
Your Assay Results May Be Wrong
Timothy Gardner
Researchers often take assay data at face value, assuming it’s accurate because it came out of an instrument. Here we explain why that can be dangerous, and how assay validation can make your science faster and better.
A Better Way to Hit-Pick Strains, Enzymes, and Anything Else
Timothy Gardner
Emphasis is placed on collecting and analyzing screening data to identify hits, but once hits are chosen, the selection criteria used to define hits is often lost. Riffyn allows users to associate decision criteria with hit data, enabling improved selection processes and faster product development.
Daniel guerra RQF6bb S4shw unsplash 1
Sep 9, 2020 – Sep 10, 2020
9:00 AM PDT

2020 Commercializing Industrial Biotechnology (CIB)

Commercializing Industrial Biotechnology is a workshop where industrial biotech thought leaders share their experiences and their views on current challenges.

Check out this event
Design of Experiments (DoE) Made Easy
Timothy Gardner
If you want to perform DoEs on your system but don’t know where to start, or if you regularly perform DoEs and are looking for a simple way to import your designs to Riffyn, check out this blog explaining DoEs, why they're powerful, and how DoE designs created in JMP® can easily be pushed to Riffyn.
What is Machine Learning?
Timothy Gardner
If you’re confused about the differences between machine learning, AI, deep learning, supervised learning, or unsupervised learning, you’re not alone. This blog explains the differences, and reveals that you may have even been doing machine learning for years without even knowing it.
False Discovery Rate: The Most Important Scientific Tool You Were Never Taught
Timothy Gardner
As a full-time scientist you test a lot of hypotheses — a lot more than one per week. If you test tens or hundreds or even thousands of samples in a single experiment, it’s guaranteed that you’ll find many false positive results, in every experiment. So what can you do about it?


Ten ways Riffyn Nexus makes R&D life better

Read more on the blog


2020 Merck Technology Symposium

See more events